Abstract:The homomeric α7 nicotinic receptor (α7 nAChR) is widely expressed in the human brain that could be activated to suppress neuroinflammation, oxidative stress and neuropathic pain. Consequently, a number of α7 nAChR agonists have entered clinical trials as anti-Alzheimer's or anti-psychotic therapies. However, high-resolution crystal structure of the full-length α7 receptor is thus far unavailable. Since acetylcholine-binding protein (AChBP) from Lymnaea stagnalis is most closely related to the α-subunit of nAChRs, it has been used as a template for the N-terminal domain of α-subunit of nAChR to study the molecular recognition process of nAChR-ligand interactions, and to identify ligands with potential nAChR-like activities. Here we report the discovery and optimization of novel acetylcholine-binding protein ligands through screening, structure-activity relationships and structure-based design. We manually screened in-house CNS-biased compound library in vitro and identified compound 1 , a piperidine derivative, as an initial hit with moderate binding affinity against AChBP (17.2% inhibition at 100 nmol/L). During the 1st round of optimization, with compound 2 (21.5% inhibition at 100 nmol/L) as the starting point, 13 piperidine derivatives with different aryl substitutions were synthesized and assayed in vitro . No apparent correlation was demonstrated between the binding affinities and the steric or electrostatic effects of aryl substitutions for most compounds, but compound 14 showed a higher affinity ( K i =105.6 nmol/L) than nicotine ( K i =777 nmol/L). During the 2nd round of optimization, we performed molecular modeling of the putative complex of compound 14 with AChBP, and compared it with the epibatidine-AChBP complex. The results suggested that a different piperidinyl substitution might confer a better fit for epibatidine as the reference compound. Thus, compound 15 was designed and identified as a highly affinitive acetylcholine-binding protein ligand. In this study, through two rounds of optimization, compound 15 ( K i =2.8 nmol/L) has been identified as a novel, piperidine-based acetylcholine-binding protein ligand with a high affinity.

Exploring the Relationship between Nicotinic Acetylcholine Receptor Ligand Size, Efficiency, Efficacy and C-loop Opening.

Micromechanical Measurement of Achbp Binding for Label-Free Drug Discovery

Structural Basis of Agonist Selectivity for Different Nachr Subtypes: Insights from Crystal Structures, Mutation Experiments and Molecular Simulations

Molecular Recognition Properties of Nicotinic Ligands Determining Selectivity Between Insect and Mammalian Receptors

Discovery, synthesis, biological evaluation and structure-based optimization of novel piperidine derivatives as acetylcholine-binding protein ligands

Ligand-specific homology modeling of human cannabinoid (CB1) receptor

The Crystal Structure of Ac-AChBP in Complex with Α-Conotoxin LvIA Reveals the Mechanism of Its Selectivity Towards Different Nachr Subtypes

Role of Acetylcholine Receptor Domains in Ion Selectivity.

Structural and dynamic insights into supra-physiological activation and allosteric modulation of a muscarinic acetylcholine receptor

Spontaneous lipid binding to the nicotinic acetylcholine receptor in a native membrane

Elucidation of the molecular basis of cholecystokinin Peptide docking to its receptor using site-specific intrinsic photoaffinity labeling and molecular modeling

Integrating Pharmacophore Into Membrane Molecular Dynamics Simulations To Improve Homology Modeling Of G Protein-Coupled Receptors With Ligand Selectivity: A(2a) Adenosine Receptor As An Example

Insights into docking and scoring neuronal α4β2 nicotinic receptor agonists using molecular dynamics simulations and QM/MM calculations

Ligand design for human acetylcholinesterase and nicotinic acetylcholine receptors, extending beyond the conventional and canonical

Conformational Complexity and Dynamics in a Muscarinic Receptor Revealed by NMR Spectroscopy.

Molecular Docking and Molecular Dynamics Simulation Studies of GPR40 Receptor–agonist Interactions

Computational study of the transmembrane domain of the acetylcholine receptor

From Crystal Structures of RgIA4 in Complex with Ac -AChBP to Molecular Determinants of Its High Potency of α9α10 nAChR.

Reliability of Docking-Based Virtual Screening for GPCR Ligands with Homology Modeled Structures: A Case Study of the Angiotensin II Type I Receptor.

From Crystal Structure Of Alpha-Conotoxin Gic In Complex With Ac-Achbp To Molecular Determinants Of Its High Selectivity For Alpha 3 Beta 2 Nachr

High Selectivity Of An Alpha-Conotoxin Lvia Analogue For Alpha 3 Beta 2 Nicotinic Acetylcholine Receptors Is Mediated By Beta 2 Functionally Important Residues